Shihao Chen

Title: Shihao Chen: Innovator in Cancer Treatment

Introduction

Shihao Chen is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of combination therapies. With a total of 2 patents, Chen's work focuses on enhancing the efficacy of cancer therapies.

Latest Patents

Chen's latest patents include groundbreaking therapies aimed at treating cancer. The first patent describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent. This innovative approach aims to improve treatment outcomes for cancer patients. The second patent outlines a method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist. This therapy also focuses on utilizing combination treatments to enhance the effectiveness of cancer care.

Career Highlights

Throughout his career, Shihao Chen has worked with notable companies in the pharmaceutical industry. He has been associated with Pfizer Corporation and Kyowa Hakko Kirin Co., Limited, where he has contributed to the development of advanced cancer therapies. His expertise and dedication to research have positioned him as a key figure in the field.

Collaborations

Chen has collaborated with esteemed colleagues, including Chia-Yang Lin and Shobha Chowdary Potluri. These collaborations have further enriched his research and development efforts in cancer treatment.

Conclusion

Shihao Chen's innovative work in cancer treatment through combination therapies showcases his commitment to improving patient outcomes. His contributions to the field are significant and continue to influence cancer research and therapy development.